Revocation of New York Ruling Letter J80522; classification of Amevive® (alefacept), Alefacept (CAS-222535-22-0), imported in bulk form and single-dose vials, from Germany
Reasoning
Revocation of New York Ruling Letter J80522; classification of Amevive® (alefacept), Alefacept (CAS-222535-22-0), imported in bulk form and single-dose vials, from Germany
Cite this ruling
CBP Ruling H207575 (30021002): Revocation of New York Ruling Letter J80522; classification of Amevive® (alefacept), Alefacept (CAS-222535-22-0), imported in bulk form and single-dose vials, from Germany
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300210
The tariff classification of PC10 monoclonal antibody andPC10 monoclonal cell line, from England.
The tariff classification of rabbit antiserum from England.
The tariff classification of Dynabeads M-450 and M-280 fromNorway.
The tariff classification of polystyrene beads doped withmonoclonal antibodies from Germany.
The tariff classification of three blood fraction products:Gammagard (IGIV),Immune Globulin Intravenous (human) fromBelgium; ATnativ, Antithrombin III (human) from Sweden; andAlbumin (human) 5% and 25% solution from Switzerland.